"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit ...

Using the 2 Stage Free Cash Flow to Equity, Abbott Laboratories fair value estimate is US$152 With US$129 share price, Abbott Laboratories appears to be trading close to its estimated fair value ...

The outlook and technical action suggest Abbott Laboratories (NYSE: ABT) will lead healthcare names like Johnson & Johnson (NYSE: JNJ) higher in 2025. While each produced a solid quarter ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. Abbott continues to execute growth businesses with excellent marketing and ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against other stocks discussed by Jim Cramer with insights on the DeepSeek AI sell-off. On the day that ...

2025 Adjusted Operating Margin Forecast: 23.5% to 24% of sales. 2025 Adjusted Tax Rate Forecast: 16% to 17%. Abbott Laboratories (NYSE:ABT) achieved a 9.5% sales growth excluding COVID testing, ...

A year after the American Academy of Pediatrics flagged what it described as "questionable marketing practices" by makers of formulas for older infants and toddlers, Abbott Laboratories is being ...

Looking at the universe of stocks we cover at Dividend Channel, on 1/15/25, Abbott Laboratories (Symbol: ABT), AbbVie Inc (Symbol: ABBV), and Phillips Edison & Co Inc (Symbol: PECO) will all trade ...